Today: 7 February 2026
Subscribe
Browse Category

Stock Market News 10 January 2026

Netflix stock: Warner Bros bid fight keeps NFLX in play ahead of earnings and CPI

Netflix stock: Warner Bros bid fight keeps NFLX in play ahead of earnings and CPI

Netflix shares fell 1.2% to $89.46 Friday, trailing a broader market rally amid a takeover battle for Warner Bros Discovery. Paramount Skydance is urging Warner shareholders to reject Netflix’s $82.7 billion cash-and-stock offer in favor of its $108.4 billion all-cash bid. Key dates ahead include U.S. CPI on Jan. 13, Netflix earnings Jan. 20, and Paramount’s tender-offer deadline Jan. 21.
10 January 2026
··
Johnson & Johnson stock dips on Trump drug-price deal — what to watch before Monday

Johnson & Johnson stock dips on Trump drug-price deal — what to watch before Monday

Johnson & Johnson shares fell 0.7% to $204.39 Friday after the company agreed to lower U.S. drug prices in exchange for tariff exemptions, with terms undisclosed. J&J will join the TrumpRx.gov platform and said it plans two new U.S. manufacturing sites. The S&P 500 rose 0.65%. Investors await the JPMorgan healthcare conference and J&J’s Jan. 21 earnings call.
10 January 2026
··
Exxon Mobil stock in focus as CEO calls Venezuela “uninvestable” while keeping return option alive

Exxon Mobil stock in focus as CEO calls Venezuela “uninvestable” while keeping return option alive

Exxon Mobil shares rose 1.38% to $124.61 Friday after CEO Darren Woods said the company may consider returning to Venezuela if legal and regulatory conditions improve. Woods called Venezuela “uninvestable” under current laws and cited past asset seizures. U.S. crude closed at $59.12 a barrel, below most producers’ break-even levels. Chevron remains the only U.S. major operating in Venezuela.
10 January 2026
··
ASML stock leaps 7% as TSMC revenue beat lifts chip gear names into CPI, earnings week

ASML stock leaps 7% as TSMC revenue beat lifts chip gear names into CPI, earnings week

ASML shares surged 6.7% to $1,273.88 Friday, leading a semiconductor rally that sent the Philadelphia SE Semiconductor Index to a record high. TSMC reported fourth-quarter revenue up 20.45% year-on-year, beating forecasts ahead of its Jan. 15 guidance update. Investors await the U.S. CPI release on Jan. 13 and ASML’s earnings on Jan. 28. Markets closed flat overall.
10 January 2026
···
Mastercard stock in focus after Trump floats 10% credit card rate cap; what to watch next

Mastercard stock in focus after Trump floats 10% credit card rate cap; what to watch next

Mastercard fell 0.8% to $575.54 Friday after President Trump proposed capping credit card interest rates at 10% for one year starting Jan. 20. Investors await details on the plan and the U.S. CPI report due Tuesday. Senator Elizabeth Warren called the proposal meaningless without legislation. Mastercard’s stock remains below its 52-week high amid regulatory concerns.
10 January 2026
·
Samsung Electronics stock clings to 139,000 won after record profit guide — what matters before Jan 29

Samsung Electronics stock clings to 139,000 won after record profit guide — what matters before Jan 29

Samsung Electronics shares closed Friday at 139,000 won, up 0.1%. The company forecast Q4 operating profit near 20 trillion won, a sharp jump from 12.17 trillion won in Q3. Investors await the Jan. 29 earnings call for details on memory and margin pressures. DRAM prices surged over 30% quarter-on-quarter, fueling expectations for further gains.
10 January 2026
··
Eli Lilly stock slides 2%: Zepbound trial data, TuneLab AI tie-up and what’s next for LLY

Eli Lilly stock slides 2%: Zepbound trial data, TuneLab AI tie-up and what’s next for LLY

Eli Lilly shares fell 2% to $1,063.56 Friday, extending a two-day decline and lagging the broader market. The drop followed late-stage trial results for a Zepbound-Taltz drug combo and news of a $1.2 billion deal to buy Ventyx Biosciences. A Form 4 filing showed Lilly Endowment sold 292,148 shares on January 7. Lilly will present at the J.P. Morgan Healthcare Conference on January 13.
10 January 2026
···
Broadcom stock jumps after Mizuho lifts target; CPI week sets up next test for AVGO

Broadcom stock jumps after Mizuho lifts target; CPI week sets up next test for AVGO

Broadcom shares jumped 3.7% to $344.97 Friday, lifting the PHLX Semiconductor Index to a record. Mizuho raised its price target on Broadcom to $480, citing “attractive valuations.” Cathie Wood’s ARK Invest bought 31,573 shares, while Broadcom’s legal chief sold 30,000 shares. The stock remains 17% below its 52-week high after a December warning on profit margins.
10 January 2026
···
Revolution Medicines stock jumps on Merck buyout buzz and an FDA breakthrough tag — what to watch Monday

Revolution Medicines stock jumps on Merck buyout buzz and an FDA breakthrough tag — what to watch Monday

Revolution Medicines shares surged 10.7% to $118.64 Friday after reports that Merck is in talks for a $28–32 billion takeover. The FDA granted Breakthrough Therapy status to its lung cancer drug zoldonrasib. Insider filings show the CFO and COO sold shares earlier in the week under pre-arranged plans. Revolution denied rumors of a separate AbbVie bid.
10 January 2026
·
Meta stock ends up after nuclear power deals as WhatsApp EU rules, China review loom

Meta stock ends up after nuclear power deals as WhatsApp EU rules, China review loom

Meta shares closed up 1.1% at $653.06 after announcing 20-year nuclear power deals with Vistra, Oklo, and TerraPower, aiming for up to 6.6 gigawatts by 2035. European and Chinese regulators launched new investigations into Meta this week. In Europe, WhatsApp Channels exceeded the EU’s regulatory threshold, triggering possible stricter rules. China will review Meta’s acquisition of AI startup Manus.
10 January 2026
···
1 … 398 399 400 401 402 … 1,170

Stock Market Today

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
New York, Feb 7, 2026, 11:29 ET — Market closed. AbbVie shares closed up 2% on Friday at $223.43, extending a second straight session of gains as U.S. stocks rallied. The stock is still roughly 9% below its 52-week high, and trading volume ran a bit under its recent average. (MarketWatch) The bounce comes as investors work through AbbVie’s post-earnings reset and what it means for 2026. The drugmaker said fourth-quarter net revenues rose 10% to $16.618 billion and adjusted profit per share—excluding certain items—was $2.71; it forecast 2026 adjusted earnings of $14.37 to $14.57 a share. Chief Executive Robert
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

7 February 2026
Bank of America shares rose 2.89% Friday to $56.53, tracking a rally in U.S. financial stocks as the Dow closed above 50,000. The bank will redeem its Series DD preferred stock and related depositary shares on March 10 at $1,000 per share. CEO Brian Moynihan donated 100,000 shares on Feb. 4, a regulatory filing showed. Key U.S. jobs and inflation data are due next week after delays.
Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

7 February 2026
Oracle shares jumped 4.65% to $142.82 Friday, ending an eight-day slide but remaining down 22% since Jan. 27. The company has set up a $20 billion at-the-market stock program and completed a $25 billion senior notes sale to fund cloud expansion. Oracle’s liabilities stood at $174.5 billion as of Nov. 30, 2025, before the new financing. Investors remain focused on dilution risks and the pace of capacity growth.
Go toTop